积极书双
Lv3
250 积分
2024-11-29 加入
-
Non-invasive plasma testing for CD274 UTR structural variations by next-generation sequencing in cancer
35分钟前
已完结
-
Targeting tumor-infiltrating tregs for improved antitumor responses
37分钟前
已完结
-
Phase I trial of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumors
41分钟前
已完结
-
First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study
49分钟前
已完结
-
gC1qR: A New Target for Cancer Immunotherapy
50分钟前
已完结
-
Optimized CAR-T therapy based on spatiotemporal changes and chemotactic mechanisms of MDSCs induced by hypofractionated radiotherapy
52分钟前
已完结
-
Phase I pharmacokinetic, safety, and preliminary efficacy study of tiragolumab in combination with atezolizumab in Chinese patients with advanced solid tumors
53分钟前
已完结
-
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
55分钟前
已完结
-
KRAS G12D mutation predicts lower TMB and drives immune suppression in lung adenocarcinoma
1小时前
已完结
-
Low-Dose Radiation Therapy Promotes Radiation Pneumonitis by Activating NLRP3 Inflammasome
1小时前
已完结